Cyteir Therapeutics Funding: $140M Raised, Series C (2021)
Cyteir Therapeutics is based in Cambridge, Massachusetts. It has raised $140M in total funding. Latest round: Series C.
Cyteir Therapeutics funding overview
Cyteir Therapeutics is based in Cambridge, Massachusetts. Cyteir Therapeutics has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2021. The round record for Cyteir Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Novo Holdings and 4 others. 10 distinct backers are named across the disclosed rounds.
Cyteir Therapeutics at a glance
Total raised
$140M
Latest round
Series C
Latest round date
February 2021
Headquarters
Cambridge, Massachusetts
Notable investors
RA Capital Management, Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Novo Holdings, Venrock, Lightstone Ventures
Frequently asked about Cyteir Therapeutics funding
How much has Cyteir Therapeutics raised?
Cyteir Therapeutics has raised $140M in total disclosed funding across the rounds on record.
Who has invested in Cyteir Therapeutics?
RA Capital Management, Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Novo Holdings are named among the investors backing Cyteir Therapeutics.
What was the latest Cyteir Therapeutics funding round?
The most recent disclosed round is a Series C, announced in February 2021.
Where is Cyteir Therapeutics based?
Cyteir Therapeutics is based in Cambridge, Massachusetts.
When did Cyteir Therapeutics last raise?
The last disclosed Cyteir Therapeutics round closed in February 2021 at Series C.
Totals shown for Cyteir Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
